We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
The Electronic Cigarettes Advisory Committee provides advice on the development of the updated NHMRC Statement on Electronic Cigarettes.
The Department of Health, Disability and Ageing has provided NHMRC with funding to develop an updated NHMRC Statement on Electronic Cigarettes to replace the previous 2022 NHMRC Statement. The aim of the updated NHMRC Statement is to better understand the current evidence relevant to the marketing and use of e-cigarettes and their impacts on individual and population health.
NHMRC has established the Electronic Cigarettes Advisory Committee under Section 39 of the National Health and Medical Research Council Act 1992.
In undertaking the update to the NHMRC Statement on Electronic Cigarettes, the Committee will:
The Electronic Cigarettes Working Committee is effective for the period 15 December 2025 to 30 June 2027 and will report to the Chief Executive Officer of NHMRC through the Electronic Cigarettes Project Team.
Members of the Committee were appointed based on their expertise in areas including research methodology and synthesis, tobacco control, e-cigarette advertising and promotion, research integrity and ethics, general practice, toxicology, pharmacology, respiratory disease, nicotine use in young people, addiction control, respiratory medicine, smoking cessation, consumer representation, biostatistics and epidemiology. Additionally, the Committee includes members with expertise in First Nations health, culturally and linguistically diverse groups, and lower socioeconomic groups. The Committee is chaired by an independent research methodology expert.
Before appointment to the Committee, shortlisted applicants were required to provide information on their interests and complete a Disclosure of Interest form.
Committee members are required to disclose their interests on an ongoing basis and consider both perceived and actual interests.
A summary of the interests disclosed by each member is available below.
Professor, School of Public Health, University of Adelaide
BMedRad, GradDip HlthSc, MPH, PhD, MGIN
Professor Munn is a systematic review, evidence implementation and guideline development methodologist. He advocates for evidence-based healthcare and for ensuring policy and practice is based on the best available evidence. He is the founding Director of Health Evidence Synthesis, Recommendations and Impact in the School of Public Health at Adelaide University; Head of the Evidence Synthesis Taxonomy Initiative; Founding Director of the Adelaide GRADE Centre; and past-Chair of the Guidelines International Network.
Professor Indigenous Health, Indigenous Health Equity Unit, Melbourne School of Population and Global Health
BaSc, MScPHP, MpH, PhD
Professor Chamberlain is a Cochrane review author and public health researcher who has worked on several reviews and Cochrane editorials. She has over 30 years' experience in reproductive and child health, including program and hospital service management, policy implementation, guideline development and evidence-based research. Her expertise and research areas include Indigenous peoples, perinatal health, and public health, transforming human societies, understanding disease and equity.
Associate Professor, National Centre for Youth Substance Use Research, University of Queensland
BA, BSc, MSc, PhD
Associate Professor Chan is a statistician, data scientist and epidemiologist whose principal research interest lies in the field of addiction epidemiology and substance misuse prevention. His current research focuses on the use of alcohol, nicotine products and cannabis in the population, and behavioural addiction such as gaming disorder. He has served as a consultant at the United Nations Office of Drugs and Crime to improve methods for monitoring global trends of illicit substance production, trafficking and use. He also serves as a biostatistician for West Moreton Health Service Group and Ipswich Hospital and as Deputy Statistical and Methodology Editor for the journal Addiction.
Associate Professor, National Drug and Alcohol Research Centre, University of New South Wales Sydney
BPsych, PhD
Associate Professor Courtney combines his background in behavioural science with research focused on smoking cessation, in particular tobacco smoking in low socio-economic status and socially disadvantaged populations. His research has a strong focus on the relationships between social disparities, including socio-economic inequalities and health behaviours and outcomes. This includes clinical trial research examining the effectiveness and safety of pharmacotherapies for smoking cessation including vaporised nicotine products, nicotine replacement therapy, varenicline and cytisine.
Senior Toxicologist, Toxicology Section, Therapeutic Goods Administration
BSc, BASc (Hon), MPH, PhD
Dr Ellis is a toxicologist and pharmacologist who is experienced in analysing and critically appraising complex pharmacological and toxicological data submitted in support of the registration of medicinal products in Australia and undertaking comprehensive assessments of risk and management. She holds membership to the Australasian College of Toxicology and Risk Assessment.
Professor, School of Public Health, University of Sydney
BSc, MSc, PhD
Professor Freeman has 25 years' experience working in the tobacco control field and is well versed in program and policy best practice. Her primary research interests include tobacco control, how online and social media influence public health, and the commercial determinants of health. Professor Freeman is an established authority on the potential of the Internet to circumvent tobacco advertising bans and has pioneered research methods in tracking and analysing online social media content.
Professor and Matthew Flinders Professor, College of Medicine and Public Health, Flinders University
BA, MPH, PhD
Professor Hefler leads a program of work to inform tobacco endgame through paradigm shifting tobacco control policies such as reducing the commercial availability of cigarettes. She is also Editor-in-Chief of the BMJ specialist journal Tobacco Control, and co-founder and co-chair of Project Sunset, an international coalition focused on research and advocacy for phasing out sales of cigarettes. Professor Hefler's tobacco control research experience spans a wide range of topics, including social marketing and use of social media, health warning labels, smoke free prisons, youth smoking prevention, tobacco use among people living with mental illness, socioeconomically disadvantaged groups, participatory community programs to reduce smoking among First Nations peoples, and tobacco industry monitoring.
Consumer Representative
BBiomedSci, MPH
Ms Horton is an experienced consumer representative with a background in epidemiology, research methods, health promotion, and policy analysis. She has more than 10 years’ experience working in research administration at the University of Tasmania and now holds a Senior Policy role in social policy development. Ms Horton has lived experience in supporting someone with tobacco dependencies and seeks to contribute her experience with this combined with her experience as a professional, consumer representative and advocate.
Associate Professor, National Centre for Epidemiology and Population Health, Australian National University
BSc, MPH, PhD
Associate Professor Maddox (Bagumani (Modewa) Clan, Papua New Guinea) leads a program of research that is focused on developing population based Indigenous heath info-systems using community driven processes to better understand and improve Indigenous health and wellbeing, including mental, emotional, spiritual and physical health. His program of research has included a strong focus on commercial tobacco use and working with Indigenous communities and health service providers to better understand, inform and evaluate programs, services and policies.
Consumer Representative
BPharm, MBA, PhD
Dr Nabi is an experienced consumer representative with a background in pharmacology and biomedical science as well as relevant experience in health research, community engagement and policy work. She brings a strong regional and multicultural voice, as well as experience as a migrant and a parent. Dr Nabi seeks to contribute her experience in reflecting lived experience, communicating community needs, evaluating health resources, and providing constructive feedback. In 2023, Dr Nabi was awarded a Medal of the Order of Australia (OAM) for her exceptional service to community health, education, and multicultural affairs.
Respiratory Physician and Head of Respiratory Medicine at Concord Hospital
MD FRACP
Professor Peters has a diverse range of research interests including respiratory physiology, asthma and lung cancer but also a particular focus on improvement in public health. He has made notable contributions in the area of tobacco control and better care of patients with lung cancer. Professor Peters previously co-chaired the Thoracic Society of Australia working party on electronic cigarettes. In 2019 he was made a Member of the Order of Australia for significant contributions to lung health through education and support of organisations.
Professor, School of Medicine and Public Health, University of Newcastle
BSc, BSc Hons (Psychology), PhD
Professor Wolfenden is a health promotion practitioner and behavioural and implementation scientist. He is Co-Director of the Cochrane People, Health Systems and Public Health Thematic Group and Director of the National Centre of Implementation Science. He holds a co-appointment and is responsible for provision of chronic disease prevention services at Hunter New England Local Health District. Professor Wolfenden is also Senior Advisor at the Sax Institute, contributing his expertise in implementation science and evidence synthesis for chronic disease prevention. His research interests include child health issues such as healthy eating, physical activity, drugs, alcohol and vaping.
General Practitioner and Executive Dean, Faculty of Health Sciences, Bond University
MBBS, MPH, PhD
Professor Zwar has over 30 years' clinical experience as a general practitioner and as a primary health care teacher and researcher. He has a national and international reputation in health services research on prevention and management of chronic illness, with a focus on respiratory and cardiovascular diseases. His other clinical, teaching and research interests include tobacco control, immunisation and travel health.